---
title: "Treatment of blepharospasm with methylphenidate: A telemedicine study"
collection: publications
permalink: /publication/2025-movement-disorder
excerpt: 'Movement Disorder'
date: 2025-12-22
tags:
  - Movement Disorder
  - Blepharospasm
  - Clinical trial
  - Neurology
  - methylphenidate
  - Emory Uiversity
venue: 'Movement Disorders'
paperurl: 'https://doi.org/10.1002/mdc3.70485'  
citation: 'Thayani M, Lopez-Castellanos R, Nalamada K,<i style="color:DodgerBlue;">Dinasarapu AR </i>, Kilic-Berkmen G, Scorr LM, Jinnah HA. Treatment of Blepharospasm with Methylphenidate - A Telemedicine Study. <i>Movement Disorders Clinical Practice </i> (2025)'  
---  
The treatment of choice for blepharospasm and related craniofacial dystonias involves local injection of botulinum toxins. However, some individuals report incomplete or short-duration responses, so additional therapies are sometimes needed.    
